603707 健友股份
交易中 05-08 10:49:57
资讯
新帖
简况
股市必读：健友股份年报 - 第四季度单季净利润同比下降30.99%
证券之星 · 05-06 01:42
股市必读：健友股份年报 - 第四季度单季净利润同比下降30.99%
每周股票复盘：健友股份（603707）Q1净利增5.07%
证券之星 · 05-02
每周股票复盘：健友股份（603707）Q1净利增5.07%
健友股份（603707）2026年一季报简析：营收净利润同比双双增长，三费占比上升明显
证券之星 · 05-01
健友股份（603707）2026年一季报简析：营收净利润同比双双增长，三费占比上升明显
健友股份(603707)3月31日股东户数3.57万户，较上期减少6.31%
证券之星 · 04-30
健友股份(603707)3月31日股东户数3.57万户，较上期减少6.31%
图解健友股份一季报：第一季度单季净利润同比增长5.07%
证券之星 · 04-30
图解健友股份一季报：第一季度单季净利润同比增长5.07%
健友股份新注册《一种依诺肝素钠注射液的预充针生产自动报警系统V4.3.0》项目的软件著作权
证券之星 · 04-17
健友股份新注册《一种依诺肝素钠注射液的预充针生产自动报警系统V4.3.0》项目的软件著作权
健友股份新注册《一种依诺肝素钠注射液的预充针自动剔废系统V4.3.0》项目的软件著作权
证券之星 · 04-09
健友股份新注册《一种依诺肝素钠注射液的预充针自动剔废系统V4.3.0》项目的软件著作权
每周股票复盘：健友股份（603707）累计回购137.9995万股
证券之星 · 04-05
每周股票复盘：健友股份（603707）累计回购137.9995万股
健友股份（603707）披露股份回购进展公告，4月2日股价下跌0.1%
证券之星 · 04-02
健友股份（603707）披露股份回购进展公告，4月2日股价下跌0.1%
每周股票复盘：健友股份（603707）健友转债将于4月22日到期兑付
证券之星 · 03-29
每周股票复盘：健友股份（603707）健友转债将于4月22日到期兑付
3月23日健友股份跌7.03%，宏利集享债券A基金重仓该股
证券之星 · 03-23
3月23日健友股份跌7.03%，宏利集享债券A基金重仓该股
每周股票复盘：健友股份（603707）“健友转债”将于4月22日到期兑付
证券之星 · 03-22
每周股票复盘：健友股份（603707）“健友转债”将于4月22日到期兑付
健友股份（603707）披露“健友转债”到期兑付暨摘牌的第二次提示性公告，3月19日股价下跌1.11%
证券之星 · 03-19
健友股份（603707）披露“健友转债”到期兑付暨摘牌的第二次提示性公告，3月19日股价下跌1.11%
健友股份（603707）披露“健友转债”到期兑付暨摘牌的第一次提示性公告，3月17日股价下跌1.29%
证券之星 · 03-17
健友股份（603707）披露“健友转债”到期兑付暨摘牌的第一次提示性公告，3月17日股价下跌1.29%
健友股份新注册《肝素钠西林瓶装盒机包装设备视觉软件V4.3.0》项目的软件著作权
证券之星 · 03-12
健友股份新注册《肝素钠西林瓶装盒机包装设备视觉软件V4.3.0》项目的软件著作权
每周股票复盘：健友股份（603707）回购进展显示已支付1,500.85万元
证券之星 · 03-08
每周股票复盘：健友股份（603707）回购进展显示已支付1,500.85万元
健友股份（603707）披露股份回购进展公告，3月2日股价下跌2.63%
证券之星 · 03-02
健友股份（603707）披露股份回购进展公告，3月2日股价下跌2.63%
每周股票复盘：健友股份（603707）子公司亚硒酸注射液获FDA批准
证券之星 · 02-08
每周股票复盘：健友股份（603707）子公司亚硒酸注射液获FDA批准
健友股份(603707.SH)子公司产品亚硒酸注射液获得美国FDA批准
智通财经 · 02-04
健友股份(603707.SH)子公司产品亚硒酸注射液获得美国FDA批准
健友股份（603707）披露股份回购进展公告，2月2日股价下跌2.01%
证券之星 · 02-02
健友股份（603707）披露股份回购进展公告，2月2日股价下跌2.01%
公司概况
公司名称：
南京健友生化制药股份有限公司
所属行业：
医药制造业
上市日期：
2017-07-19
主营业务：
南京健友生化制药股份有限公司的主营业务是药品研发、生产、销售。公司的主要产品是标准肝素原料药、制剂、CDMO。截至报告期末，公司及子公司共拥有超过100项境外药品注册批件、超过30项中国药品注册批件。
发行价格：
7.21
{"stockData":{"symbol":"603707","market":"SH","secType":"STK","nameCN":"健友股份","latestPrice":9.1,"timestamp":1778208597000,"preClose":9.1,"halted":0,"volume":3863600,"delay":0,"changeRate":0,"floatShares":1616000000,"shares":1616000000,"eps":0.3627,"marketStatus":"交易中","change":0,"latestTime":"05-08 10:49:57","open":9.1,"high":9.15,"low":9.09,"amount":35221200,"amplitude":0.0066,"askPrice":9.1,"askSize":1035,"bidPrice":9.09,"bidSize":5267,"shortable":0,"etf":0,"ttmEps":0.3627,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1778211000000},"marketStatusCode":2,"adr":0,"adjPreClose":9.1,"symbolType":"stock","openAndCloseTimeList":[[1778203800000,1778211000000],[1778216400000,1778223600000]],"highLimit":10.01,"lowLimit":8.19,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1615643839,"isCdr":false,"pbRate":2.12,"roa":"--","peRate":25.089606,"roe":"1.28%","epsLYR":0.36,"committee":0.580976,"marketValue":14702000000,"turnoverRate":0.0024,"status":2,"floatMarketCap":14702000000},"requestUrl":"/m/hq/s/603707/wiki","defaultTab":"wiki","newsList":[{"id":"2633294059","title":"股市必读：健友股份年报 - 第四季度单季净利润同比下降30.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633294059","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633294059?lang=zh_cn&edition=full","pubTime":"2026-05-06 01:42","pubTimestamp":1778002931,"startTime":"0","endTime":"0","summary":"2025年第四季度主营收入10.65亿元，同比增长27.45%；单季度归母净利润1.52亿元，同比下降30.99%；单季度扣非净利润1.19亿元，同比下降49.27%。此次转回应增加2025年度归母净利润15,309.23万元，相关数据业经会计师事务所审计确认。健友股份2025年年度报告摘要公司2025年实现营业收入3,990,678,037.30元，同比增长1.71%；归母净利润581,536,153.84元，同比下降29.61%；扣非后归母净利润502,720,059.96元，同比下降35.73%。利润总额为699,416,366.86元，同比下降29.50%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600000523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632641906","title":"每周股票复盘：健友股份（603707）Q1净利增5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632641906","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632641906?lang=zh_cn&edition=full","pubTime":"2026-05-02 02:24","pubTimestamp":1777659852,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，健友股份报收于9.18元，较上周的9.31元下跌1.4%。本周，健友股份4月29日盘中最高价报9.49元。业绩披露要点：2026年一季度归母净利润8901.19万元，同比上升5.07%。公司公告汇总：拟转回存货跌价准备18,010.86万元，将增厚2025年净利15,309.23万元。股本股东变化截至2026年3月31日，健友股份股东户数为3.57万户，较2025年12月31日减少2403.0户，减幅6.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0186","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632335660","title":"健友股份（603707）2026年一季报简析：营收净利润同比双双增长，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2632335660","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632335660?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:27","pubTimestamp":1777588078,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期健友股份发布2026年一季报。截至本报告期末，公司营业总收入9.29亿元，同比上升4.91%，归母净利润8901.19万元，同比上升5.07%。本报告期健友股份三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达34.31%。去年的净利率为14.57%，算上全部成本后，公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100005364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631684399","title":"健友股份(603707)3月31日股东户数3.57万户，较上期减少6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631684399","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631684399?lang=zh_cn&edition=full","pubTime":"2026-04-30 17:31","pubTimestamp":1777541467,"startTime":"0","endTime":"0","summary":"证券之星消息，近日健友股份披露，截至2026年3月31日公司股东户数为3.57万户，较12月31日减少2403.0户，减幅为6.31%。在化学制药行业个股中，健友股份股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.61万户。从股价来看，2025年12月31日至2026年3月31日，健友股份区间涨幅为8.42%，在此期间股东户数减少2403.0户，减幅为6.31%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000056205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0239","BK0046","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631528453","title":"图解健友股份一季报：第一季度单季净利润同比增长5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631528453","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631528453?lang=zh_cn&edition=full","pubTime":"2026-04-30 03:18","pubTimestamp":1777490337,"startTime":"0","endTime":"0","summary":"证券之星消息，健友股份2026年一季报显示，一季度公司主营收入9.29亿元，同比上升4.91%；归母净利润8901.19万元，同比上升5.07%；扣非净利润5657.3万元，同比下降24.89%；负债率34.65%，投资收益541.05万元，财务费用4034.46万元，毛利率32.31%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000009213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628248032","title":"健友股份新注册《一种依诺肝素钠注射液的预充针生产自动报警系统V4.3.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2628248032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628248032?lang=zh_cn&edition=full","pubTime":"2026-04-17 02:08","pubTimestamp":1776362895,"startTime":"0","endTime":"0","summary":"证券之星消息，近日健友股份新注册了《一种依诺肝素钠注射液的预充针生产自动报警系统V4.3.0》项目的软件著作权。今年以来健友股份新注册软件著作权3个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了1.42亿元，同比减18.47%。通过天眼查大数据分析，南京健友生化制药股份有限公司共对外投资了11家企业，参与招投标项目333次；财产线索方面有商标信息24条，专利信息142条，著作权信息1条；此外企业还拥有行政许可182个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041700003118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","603707","159180","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626929901","title":"健友股份新注册《一种依诺肝素钠注射液的预充针自动剔废系统V4.3.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2626929901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626929901?lang=zh_cn&edition=full","pubTime":"2026-04-09 01:52","pubTimestamp":1775670738,"startTime":"0","endTime":"0","summary":"证券之星消息，近日健友股份（603707）新注册了《一种依诺肝素钠注射液的预充针自动剔废系统V4.3.0》项目的软件著作权。今年以来健友股份新注册软件著作权2个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了1.42亿元，同比减18.47%。通过天眼查大数据分析，南京健友生化制药股份有限公司共对外投资了11家企业，参与招投标项目332次；财产线索方面有商标信息24条，专利信息142条；此外企业还拥有行政许可176个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040900001350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603707","BK0186","159180","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625447616","title":"每周股票复盘：健友股份（603707）累计回购137.9995万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2625447616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625447616?lang=zh_cn&edition=full","pubTime":"2026-04-05 02:14","pubTimestamp":1775326452,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，健友股份报收于9.67元，较上周的9.69元下跌0.21%。截至2026年3月31日，已累计回购137.9995万股，占总股本0.09%，支付金额1,500.85万元，回购价格区间为9.56元/股至11.66元/股。健友股份关于“健友转债”转股结果暨股份变动的公告截至2026年3月31日，累计已有935,000元“健友转债”转为公司普通股，累计转股股数26,905股，占转股前公司股份总额的0.002%。2026年1月1日至3月31日，有209,000元“健友转债”转股，转股数8,583股。公司总股本由1,615,635,256股增至1,615,643,839股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500000498.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","603707","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624008355","title":"健友股份（603707）披露股份回购进展公告，4月2日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624008355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624008355?lang=zh_cn&edition=full","pubTime":"2026-04-02 22:43","pubTimestamp":1775140992,"startTime":"0","endTime":"0","summary":"截至2026年4月2日收盘，健友股份报收于9.95元，较前一交易日下跌0.1%，最新总市值为160.76亿元。该股当日开盘9.95元，最高10.03元，最低9.86元，成交额达1.15亿元，换手率为0.72%。公告显示，南京健友生化制药股份有限公司于2025年4月28日召开董事会，审议通过回购股份议案，并经2025年5月20日股东大会审议通过。截至2026年3月31日，已累计回购137.9995万股，占总股本0.09%，支付金额1,500.85万元，回购价格区间为9.56元/股至11.66元/股。上述回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200042810.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0239","603707","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623966333","title":"每周股票复盘：健友股份（603707）健友转债将于4月22日到期兑付","url":"https://stock-news.laohu8.com/highlight/detail?id=2623966333","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623966333?lang=zh_cn&edition=full","pubTime":"2026-03-29 04:25","pubTimestamp":1774729512,"startTime":"0","endTime":"0","summary":"截至2026年3月27日收盘，健友股份报收于9.69元，较上周的9.82元下跌1.32%。本周，健友股份3月26日盘中最高价报9.87元。公司公告汇总健友股份发布关于“健友转债”到期兑付暨摘牌的第三次提示性公告。“健友转债”将于2026年4月22日到期兑付并摘牌，兑付登记日为当日，兑付本息金额为109.00元/张（含税）。兑付资金发放日为2026年4月23日。2026年4月17日为最后交易日，自4月20日起停止交易；4月22日为最后转股日，4月23日起摘牌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032900001079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603707","BK0186","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621775216","title":"3月23日健友股份跌7.03%，宏利集享债券A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621775216","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621775216?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:29","pubTimestamp":1774254586,"startTime":"0","endTime":"0","summary":"证券之星消息，3月23日健友股份跌7.03%，收盘报9.13元，换手率1.47%，成交量23.79万手，成交额2.22亿元。重仓健友股份的公募基金请见下表：该股最近90天内共有2家机构给出评级，买入评级2家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为宏利基金的宏利集享债券A。宏利集享债券A目前规模为1.19亿元，最新净值1.0108，较上一交易日上涨0.09%。该公募基金现任基金经理为刘晓晨。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025046.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603707","BK0186","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621769799","title":"每周股票复盘：健友股份（603707）“健友转债”将于4月22日到期兑付","url":"https://stock-news.laohu8.com/highlight/detail?id=2621769799","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621769799?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:17","pubTimestamp":1774120630,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，健友股份报收于9.82元，较上周的9.84元下跌0.2%。本周，健友股份3月16日盘中最高价报10.17元。2026年4月17日为最后交易日，4月20日起停止交易，4月23日起摘牌。截至2026年4月22日收市后登记在册的持有人将获得兑付。2026年4月20日至4月22日期间可转债仍可转股，当前转股价格为24.34元/股。健友股份发布“健友转债”到期兑付暨摘牌的第二次提示性公告，明确2026年4月22日为最后转股日，未转股的可转债将按面值109%赎回。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200001250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603707","BK0186","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620922180","title":"健友股份（603707）披露“健友转债”到期兑付暨摘牌的第二次提示性公告，3月19日股价下跌1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620922180","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620922180?lang=zh_cn&edition=full","pubTime":"2026-03-19 22:28","pubTimestamp":1773930500,"startTime":"0","endTime":"0","summary":"截至2026年3月19日收盘，健友股份报收于9.83元，较前一交易日下跌1.11%，最新总市值为158.82亿元。该股当日开盘9.85元，最高9.96元，最低9.8元，成交额达9721.4万元，换手率为0.61%。近日，健友股份发布《关于“健友转债”到期兑付暨摘牌的第二次提示性公告》。公告显示，南京健友生化制药股份有限公司发行的“健友转债”将于2026年4月22日到期，兑付登记日为2026年4月22日，兑付本息金额为109.00元人民币/张（含税），兑付资金发放日为2026年4月23日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900039808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603707","BK0186","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620473095","title":"健友股份（603707）披露“健友转债”到期兑付暨摘牌的第一次提示性公告，3月17日股价下跌1.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620473095","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620473095?lang=zh_cn&edition=full","pubTime":"2026-03-17 22:31","pubTimestamp":1773757875,"startTime":"0","endTime":"0","summary":"截至2026年3月17日收盘，健友股份报收于9.92元，较前一交易日下跌1.29%，最新总市值为160.27亿元。该股当日开盘10.05元，最高10.12元，最低9.92元，成交额达1.12亿元，换手率为0.69%。近日，南京健友生化制药股份有限公司发布《关于“健友转债”到期兑付暨摘牌的第一次提示性公告》。公告显示，公司发行的“健友转债”将于2026年4月22日到期，兑付登记日为2026年4月22日，兑付本息金额为109.00元人民币/张（含税），兑付资金发放日为2026年4月23日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700042162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0186","BK0239","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618901927","title":"健友股份新注册《肝素钠西林瓶装盒机包装设备视觉软件V4.3.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2618901927","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618901927?lang=zh_cn&edition=full","pubTime":"2026-03-12 01:52","pubTimestamp":1773251539,"startTime":"0","endTime":"0","summary":"证券之星消息，近日健友股份（603707）新注册了《肝素钠西林瓶装盒机包装设备视觉软件V4.3.0》项目的软件著作权。今年以来健友股份新注册软件著作权1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了1.42亿元，同比减18.47%。通过天眼查大数据分析，南京健友生化制药股份有限公司共对外投资了11家企业，参与招投标项目332次；财产线索方面有商标信息24条，专利信息141条；此外企业还拥有行政许可163个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031200001162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0186","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617684146","title":"每周股票复盘：健友股份（603707）回购进展显示已支付1,500.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617684146","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617684146?lang=zh_cn&edition=full","pubTime":"2026-03-08 01:55","pubTimestamp":1772906113,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：回购进展显示已支付1,500.85万元，占总股本0.09% 公司公告汇总：回购价格区间为9.56元/股至11.66元/股，未超上限 公司公告汇总南京健友生化制药股份有限公司于2025年4月28日召开董事会，审议通过回购股份议案，并经2025年5月20日股东大会审议通过。截至2026年2月28日，已累计回购137.9995万股，占总股本0.09%，支付金额1,500.85万元，成交价格区间为9.56元/股至11.66元/股。上述回购进展符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0046","BK0239","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616834356","title":"健友股份（603707）披露股份回购进展公告，3月2日股价下跌2.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616834356","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616834356?lang=zh_cn&edition=full","pubTime":"2026-03-02 22:54","pubTimestamp":1772463258,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，健友股份报收于9.64元，较前一交易日下跌2.63%，最新总市值为155.75亿元。该股当日开盘9.83元，最高9.87元，最低9.61元，成交额达1.3亿元，换手率为0.83%。近日，健友股份发布《关于股份回购进展的公告》。公告显示，公司于2025年4月28日召开董事会，审议通过回购股份议案，并经2025年5月20日股东大会审议通过。上述回购进展符合相关规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200040195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","603707","BK0186","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609526534","title":"每周股票复盘：健友股份（603707）子公司亚硒酸注射液获FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2609526534","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609526534?lang=zh_cn&edition=full","pubTime":"2026-02-08 02:47","pubTimestamp":1770490029,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，健友股份报收于9.77元，较上周的9.47元上涨3.17%。本周关注点来自公司公告汇总：子公司健进制药亚硒酸注射液获美国FDA批准。健友股份关于子公司产品亚硒酸注射液获得美国FDA批准的公告南京健友生化制药股份有限公司子公司健进制药有限公司收到美国食品药品监督管理局通知，其申报的亚硒酸注射液获得ANDA批准。新批准产品尚未在美国上市销售，短期内对公司业绩无重大影响，未来销售情况存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0186","BK0046","BK0239","603707"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608354974","title":"健友股份(603707.SH)子公司产品亚硒酸注射液获得美国FDA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2608354974","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608354974?lang=zh_cn&edition=full","pubTime":"2026-02-04 17:25","pubTimestamp":1770197116,"startTime":"0","endTime":"0","summary":"智通财经APP讯，健友股份(603707.SH)发布公告，公司子公司健进制药有限公司(简称“健进制药”)于近日收到美国食品药品监督管理局(简称“美国FDA”)签发的亚硒酸注射液(600mcg/10mL)的ANDA批准通知(ANDA号：219472)。适应症：适用于需要肠外营养的成人与儿科患者，作为肠外营养液中硒的来源，用于当口服或肠内营养无法实施、不足或存在禁忌时。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"健友股份(603707.SH)子公司产品亚硒酸注射液获得美国FDA批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","603707","BK0186","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608860956","title":"健友股份（603707）披露股份回购进展公告，2月2日股价下跌2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608860956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608860956?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:41","pubTimestamp":1770043279,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，健友股份报收于9.28元，较前一交易日下跌2.01%，最新总市值为149.93亿元。该股当日开盘9.43元，最高9.63元，最低9.25元，成交额达1.28亿元，换手率为0.84%。近日，健友股份发布《关于股份回购进展的公告》。公告显示，公司于2025年4月28日召开董事会，审议通过回购股份议案，并经2025年5月20日股东大会审议通过。上述回购进展符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200039489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0186","603707","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1778208604929,"stockEarnings":[{"period":"1week","weight":-0.0087},{"period":"1month","weight":-0.0589},{"period":"3month","weight":-0.0686},{"period":"6month","weight":-0.1043},{"period":"1year","weight":-0.1189},{"period":"ytd","weight":0.0078}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0745},{"period":"3month","weight":0.0282},{"period":"6month","weight":0.0457},{"period":"1year","weight":0.2505},{"period":"ytd","weight":0.0532}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南京健友生化制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"35693人(较上一季度减少6.31%)","perCapita":"45265股","listingDate":"2017-07-19","address":"江苏省南京市浦口区高新开发区MA010-1号地","registeredCapital":"161564万元","survey":" 南京健友生化制药股份有限公司的主营业务是药品研发、生产、销售。公司的主要产品是标准肝素原料药、制剂、CDMO。截至报告期末，公司及子公司共拥有超过100项境外药品注册批件、超过30项中国药品注册批件。","listedPrice":7.21},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健友股份(603707)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健友股份(603707)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健友股份,603707,健友股份股票,健友股份股票老虎,健友股份股票老虎国际,健友股份行情,健友股份股票行情,健友股份股价,健友股份股市,健友股份股票价格,健友股份股票交易,健友股份股票购买,健友股份股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健友股份(603707)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健友股份(603707)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}